Class 1 new drugs declared by 7 "leading pharmaceutical enterprises" in recent 5 years in China
-
Last Update: 2016-05-22
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In the past six years (2011-2016 / 5 / 20), seven leading pharmaceutical companies have applied for class 1 new drugs (including chemical drugs, class 1.1 and biological products, class 1) as follows: display by variety, such as betting: the listing application of repagliptin phosphate has been withdrawn; the R & D investment in 2015 is 892 million yuan; note: the R & D investment in 2015 is 828 million yuan; note: the R & D investment in 2015 of biopharmaceutical industry in China is 1.302 billion yuan Note: R & D investment in 2015 is 404 million yuan
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
